The growing role of multi-omics within drug discovery Harnessing multi-omics and AI, researchers are transforming drug discovery by revealing disease mechanisms, pinpointing therapeutic targets, and speeding up development.

https://www.drugdiscoverynews.com/the-growing-role-of-multi-omics-within-drug-discovery-17097 Drug discovery has long been a high-risk, high-reward endeavor. Developing a new therapeutic from initial concept to market approval can take over a decade and cost more than $2 billion on average. Despite these staggering investments, the failure rate remains high, with many drugs faltering in late-stage clinical trials due to unforeseen toxicity, lack of efficacy, or poor patient stratification. Traditional approaches often focus on targeting a single molecule or pathway, an approach increasingly recognized as insufficient for tackling complex diseases such as cancer, neurodegeneration, and autoimmune disorders.